Selective p300 degradation via peptide PROTAC: a new therapeutic strategy for advanced prostate cancers
Ling-Yu Wang
Affiliations
Ling-Yu Wang
Department of Biochemistry and Molecular Biology, Chang Gung University, Taoyuan 33302, Taiwan; Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan 33305, Taiwan; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan; Corresponding author. Department of Biochemistry and Molecular Biology, Chang Gung University, No.259, Wenhua 1st Rd., Guishan District, Taoyuan City 33302, Taiwan.
